Chemed Co. (NYSE:CHE) Shares Bought by Xponance Inc.

Xponance Inc. raised its position in Chemed Co. (NYSE:CHE) by 5.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,973 shares of the company’s stock after buying an additional 103 shares during the quarter. Xponance Inc.’s holdings in Chemed were worth $1,045,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. State Street Corp lifted its position in Chemed by 0.8% during the third quarter. State Street Corp now owns 464,354 shares of the company’s stock valued at $279,063,000 after buying an additional 3,564 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after acquiring an additional 15,791 shares during the period. Boston Trust Walden Corp lifted its holdings in shares of Chemed by 10.0% during the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock valued at $128,303,000 after acquiring an additional 22,105 shares in the last quarter. FMR LLC boosted its position in Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after purchasing an additional 45,917 shares during the period. Finally, Copeland Capital Management LLC increased its holdings in Chemed by 16.8% in the 4th quarter. Copeland Capital Management LLC now owns 151,623 shares of the company’s stock valued at $80,330,000 after purchasing an additional 21,834 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CHE has been the subject of several analyst reports. Royal Bank of Canada upped their target price on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research report on Friday, March 14th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

Chemed Trading Down 1.2 %

CHE opened at $594.41 on Monday. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $648.29. The firm has a market cap of $8.70 billion, a price-to-earnings ratio of 30.04, a PEG ratio of 2.15 and a beta of 0.43. The company has a fifty day simple moving average of $567.72 and a 200 day simple moving average of $565.35.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed’s dividend payout ratio is presently 10.05%.

Insider Transactions at Chemed

In other Chemed news, VP Brian C. Judkins acquired 145 shares of the stock in a transaction on Monday, December 30th. The stock was purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.